TipRanks
Go Ultimate55% OFF

Comparison Results

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
RXDProShares UltraShort Health Care$12.35―0.95%2.99M
XLVHealth Care Select Sector SPDR Fund$184.87$197.34(6.74% Upside)0.08%48.89B
VHTVanguard Health Care ETF$342.33$385.10(12.49% Upside)0.09%20.70B
IBBiShares Biotechnology ETF$217.61$272.57(25.25% Upside)0.44%11.52B
XBISPDR S&P BIOTECH ETF$155.98$255.77(63.98% Upside)0.35%11.05B
IYHiShares U.S. Healthcare ETF$77.81$83.75(7.63% Upside)0.37%4.63B
IXJiShares Global Healthcare ETF$112.66$120.38(6.85% Upside)0.38%4.62B
FHLCFidelity MSCI Health Care Index ETF$88.56$97.70(10.32% Upside)0.08%3.95B
IHIiShares U.S. Medical Devices ETF$54.59$60.58(10.97% Upside)0.37%3.73B

International Listings

OTC and non-US listings of funds similar to RXL.

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
XDWHFXtrackers MSCI World Health Care UCITS ETF$66.01$71.02(7.60% Upside)0.26%4.41B

Performance Comparison

-40%-20%0%20%40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
RXDProShares UltraShort Health Care12.35-8.22-39.97%
XLVHealth Care Select Sector SPDR Fund184.8742.8030.12%
VHTVanguard Health Care ETF342.3376.4828.77%
IBBiShares Biotechnology ETF217.6160.4738.48%
XBISPDR S&P BIOTECH ETF155.9846.5942.59%
IYHiShares U.S. Healthcare ETF77.8117.6829.39%
IXJiShares Global Healthcare ETF112.6622.8025.38%
FHLCFidelity MSCI Health Care Index ETF88.5619.8928.96%
IHIiShares U.S. Medical Devices ETF54.59-5.85-9.69%

ETFs Similar to RXL FAQ

What is the cheapest alternative to RXL?
Among the ETFs similar to RXL, XLV (Health Care Select Sector SPDR Fund) has the lowest expense ratio, at 0.08% a year, compared with 0.95% for RXL.
RXL vs. RXD: what is the difference?
RXD (ProShares UltraShort Health Care) is the first ETF in RXL's similar-ETF list. It has $2.99M in assets under management and a 0.95% expense ratio, against $112.63M and 0.95% for RXL. Compare their performance, price targets and Smart Scores in the table above.